Regeneron (REGN) Reports Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ACN
5. AZN
6. ROIV
7. AAPL
8. QCOM
9. NVDA
10. USO

Go back to Regeneron (REGN) Reports Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma
Regeneron (NASDAQ: REGN) Delayed: 812.17 -15.55 (1.88%)
Previous Close $827.72    52 Week High $592.36 
Open $814.36    52 Week Low $325.35 
Day High $821.17    P/E 213.17 
Day Low $799.42    EPS $3.81 
Volume 223,668